You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Boehringer Ingelheim
Merck
Johnson and Johnson
McKesson

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

CHLOROQUINE PHOSPHATE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for chloroquine phosphate and what is the scope of freedom to operate?

Chloroquine phosphate is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Hikma Pharms, Impax Labs, Ipca Labs Ltd, Md Pharm, Natco Pharma Ltd, Purepac Pharm, Teva, and Watson Labs, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for chloroquine phosphate. Two suppliers are listed for this compound.

Recent Clinical Trials for CHLOROQUINE PHOSPHATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
CMN "20 de Noviembre"Phase 1
Bahrain Defence Force Royal Medical Services, Military HospitalPhase 2/Phase 3
Ebrahim Khalil Kanoo Community Medical CenterPhase 2/Phase 3

See all CHLOROQUINE PHOSPHATE clinical trials

Pharmacology for CHLOROQUINE PHOSPHATE
Drug ClassAntimalarial

US Patents and Regulatory Information for CHLOROQUINE PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 083082-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Impax Labs CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 080880-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 087979-001 Dec 21, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Purepac Pharm CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 080886-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ipca Labs Ltd CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 090610-001 Dec 3, 2009 AA RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Baxter
Express Scripts
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.